Vantive
Vanessa Danielson is a seasoned professional in health economics and market access, currently serving as Vice President Global HEMAR at Vantive since February 2025. Vanessa also holds a position as a NICE Technology Appraisal Committee Member since June 2023. Prior roles include Vice President Global Health Economics, Market Access and Reimbursement at Baxter Healthcare Corporation, and Vice President, Global PHEMAR and Evidence at LivaNova. Additionally, Vanessa worked at ICON plc as Senior Principal in Global Pricing, Market Access and Clinical Research. Vanessa's educational background includes a Master’s degree in Health Economics from City University, London, and a Post Graduate Executive Education in R&D Innovation Leadership from Harvard Business School, where Vanessa graduated with distinction.
This person is not in any teams
This person is not in any offices
Vantive
5 followers
Vantive is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams everywhere. For 70 years, our team has driven meaningful innovations in kidney care. As we build on our legacy, we are deepening our commitment to elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies. Greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients— that is what Vantive aspires to deliver.